Wells Fargo’s Cue Health Inc. Common Stock HLTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-4,125
Closed -$779 7673
2024
Q1
$779 Buy
4,125
+11
+0.3% +$2 ﹤0.01% 6208
2023
Q4
$668 Buy
4,114
+39
+1% +$13 ﹤0.01% 6324
2023
Q3
$1.8K Sell
4,075
-72
-2% -$33 ﹤0.01% 6104
2023
Q2
$1.53K Sell
4,147
-19,069
-82% -$16.3K ﹤0.01% 6255
2023
Q1
$42.3K Buy
23,216
+19,768
+573% +$43K ﹤0.01% 5253
2022
Q4
$7.14K Buy
3,448
+1,308
+61% +$4.13K ﹤0.01% 5676
2022
Q3
$7K Sell
2,140
-458
-18% -$1.62K ﹤0.01% 5830
2022
Q2
$8K Sell
2,598
-2,438
-48% -$13.2K ﹤0.01% 5858
2022
Q1
$33K Sell
5,036
-4,161
-45% -$37.6K ﹤0.01% 5832
2021
Q4
$123K Buy
9,197
+7,947
+636% +$87.4K ﹤0.01% 5526
2021
Q3
$15K Buy
+1,250
New +$19.7K ﹤0.01% 6080

Other funds holding HLTH

Wells Fargo's HLTH Position: Q2 2024 in Review

Wells Fargo sold out of Cue Health Inc. Common Stock (HLTH) in Q2 2024, closing a stake of 4,125 shares — an estimated $779 sold.

Wells Fargo first reported a position in HLTH in Q3 2021 and held it in 11 quarters. The position peaked at $123K in Q4 2021. 9 funds tracked by Wall St. Rank hold HLTH as of Q2 2024.

  • Wells Fargo reported no remaining Cue Health Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Wells Fargo sold 4,125 Cue Health Inc. Common Stock shares in Q2 2024, an estimated $779.
  • Wells Fargo first reported a position in Cue Health Inc. Common Stock in Q3 2021 and held it in 11 quarters.
  • Wells Fargo's Cue Health Inc. Common Stock position peaked at $123K in Q4 2021.
  • 9 funds tracked by Wall St. Rank held Cue Health Inc. Common Stock as of Q2 2024.

Based on Wells Fargo's 13F filing for Q2 2024, filed 13 Aug 2024.